Log In
    ZOMDF
    $0.09
    (2.01%)
    FLWS
    $3.72
    (-1.33%)
    ACCO
    $3.84
    (-5.42%)
    ARLP
    $24.4
    (2.31%)
    AUIAF
    $0.17
    (12.03%)
    AZZ
    $143.6
    (-0.31%)
    BTBT
    $1.67
    (1.21%)
    BTM
    $0.49
    (0%)
    CVKD
    $3.1
    (-1.9%)
    LCE:CA
    $0.28
    (-1.72%)
    COCP
    $0.98
    (-3.73%)
    CDRO
    $9.5
    (-0.63%)
    CVGI
    $4.86
    (-0.41%)
    LODE
    $4.1
    (5.94%)
    CMTL
    $1.94
    (3.74%)
    CNDT
    $1.53
    (-2.55%)
    CXW
    $30.62
    (4.51%)
    CMLS
    $0.01
    (0%)
    DRCT
    $2.66
    (-1.85%)
    DLHC
    $5.17
    (-1.52%)
    SSP
    $3.15
    (0%)
    ELDN
    $4.21
    (7.12%)
    EVC
    $11.71
    (-1.6%)
    EDRY
    $22.08
    (2.17%)
    ESEA
    $69.19
    (1.53%)
    FAT
    $0.16
    (0%)
    RAIL
    $8.15
    (0.87%)
    GDEV
    $11.99
    (-1.48%)
    GOVX
    $1.16
    (-2.52%)
    GOCO
    $0.3
    (0%)
    GHM
    $106.65
    (0.5%)
    GLDD
    $17
    (0%)
    GYRE
    $7.58
    (-1.88%)
    HMENF
    $1.82
    (5.32%)
    III
    $4.05
    (-0.25%)
    IPOOF
    $10.4
    (2.47%)
    KELYA
    $13.32
    (-1.41%)
    KTOS
    $50.38
    (0.08%)
    LUCK
    $7.06
    (-2.75%)
    MAIA
    $1.47
    (0%)
    MGROF
    $0.25
    (-0.49%)
    NTRB
    $3.06
    (0.99%)
    OCGN
    $1.5
    (0%)
    PERF
    $1.75
    (1.74%)
    QMCI
    $0.15
    (0%)
    RGP
    $4.61
    (-2.12%)
    SGA
    $8.91
    (-0.56%)
    SHWZ
    $0
    (0%)
    SHIP
    $14.47
    (2.05%)
    SLQT
    $0.78
    (7.04%)
    SKYX
    $1.18
    (13.46%)
    SNAL
    $4.06
    (11.54%)
    GEO
    $29.65
    (2.14%)
    ODP
    $28
    (0%)
    TNXP
    $12.78
    (0.55%)
    TSQ
    $6.69
    (-3.88%)
    TZOO
    $10.79
    (-5.52%)
    UNCY
    $5.43
    (0%)
    VVX
    $76.81
    (1.79%)
    VNCE
    $6.6
    (4.51%)
    XELB
    $1.48
    (-3.9%)
    ZOMDF
    $0.09
    (2.01%)
    FLWS
    $3.72
    (-1.33%)

    channelchek-in

    ‌
    7/8/2026

    Chemomab and Scipher Merge to Bring AI-Guided Precision Medicine to Rheumatoid Arthritis

    Two small-cap biotechs are betting that artificial intelligence can succeed where a decade of drug development has stalled. Chemomab Therapeutics (Nasdaq: CMMB) and Scipher Medicine announced this morning that they have entered into a definitive merger agreement, combining Chemomab’s clinical-stage antibody nebokitug with Scipher’s AI-powered precision medicine platform to attack rheumatoid arthritis from a completely different angle than anything currently on the market.

    0
    3 min read
    • ‌
      Noble Capital Markets Research Morning Call

      Noble Capital Markets Research Morning Call

      Today’s Noble Capital Markets equity research reports, available with free...

      147 min read

    • Why the Fed’s July Meeting Matters More for Small Caps Than Anyone Else

      3 min read

    • Receive FREE Research, News, Video, and Event Updates in Your Inbox!

    • The Real AI Trade Nobody’s Talking About: Why Data Center Cooling Just Became a Billion-Dollar Business

      4 min read
    View all

    News

    7/8/2026

    Release – AZZ Inc. Reports Fiscal Year 2027 First Quarter Results

    9 min read
    ‌
    Release – AZZ Inc. Reports Fiscal Year 2027 First Quarter Results
    7/8/2026

    Release – MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial

    6 min read
    ‌
    Release – MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
    7/8/2026

    Chemomab and Scipher Merge to Bring AI-Guided Precision Medicine to Rheumatoid Arthritis

    3 min read
    ‌
    Chemomab and Scipher Merge to Bring AI-Guided Precision Medicine to Rheumatoid Arthritis
    7/8/2026

    Release – Research Analyst Report on NanoViricides Rates Company “Outperform”; Separately, A “Fireside Chat” Interview of the Company’s President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily

    8 min read
    ‌
    Release – Research Analyst Report on NanoViricides Rates Company “Outperform”; Separately, A “Fireside Chat” Interview of the Company’s President Dr. Anil Diwan Hosted by Mr. Dave Donlin was Published by StockInvestor Daily
    View all

    Research Reports

    Commercial Vehicle Group (CVGI) – First Raise Under Capital on Demand AgreementCVG(FreightCar America (RAIL) – Strong Order Activity Reinforces OutlookFA(CoreCivic, Inc. (CXW) – Validation of Asset WorthCI(NanoViricides (NNVC) – Novel Technology With Broad-Spectrum Antiviral Applications In DevelopmentN(N
    View all

    Video Content

  • ‌
    First Phosphate Corp.

    First Phosphate Corp.

    C-Suite Interview
    6/22/2026
  • ‌
    DHI Group Inc.

    DHI Group Inc.

    Conference Presentation
    6/4/2026
  • ‌
    Ocugen

    Ocugen

    Conference Presentation
    6/4/2026
  • ‌
    T3 Defense Inc.

    T3 Defense Inc.

    Conference Presentation
    6/4/2026
    • View all

    Movers

    Symbol
    Change
    ELTX
    24.64%
    BABX
    22.02%
    CBUS
    21.33%
    TC
    20.98%
    VANI
    18.52%
    View all
    Log In